Pharmafile Logo

Confidential contracting

- PMLiVE

UCB bags FDA approval for epilepsy drug Briviact

Wins US licence as the add-on treatment is launched in Germany and the UK

- PMLiVE

Dr Holger Adelmann joins DIA EMEA

Succeeds Dr Jytte Lynvig as senior vice president and managing director

- PMLiVE

AstraZeneca wins EU approvals for Zurampic and Brilique

Its gout drug receives a licence and antiplatelet therapy gains a new indication

- PMLiVE

The price is right?

To market new innovation against a backdrop of restricted budgets, companies must work hard - and start early

- PMLiVE

Celebrating excellence

Recognising excellence in improving patient outcomes

- PMLiVE

Sustainable solutions

Bayer's Alex Moscho on working towards long-term answers in healthcare

- PMLiVE

Pfizer and Allergan: The challenge starts now

The Pfizer and Allergan merger is a game changer in the pharmaceutical industry, creating the biggest drug maker in the world. The complexities of reaching this landmark agreement cannot be...

- PMLiVE

Multiplicity

After years of growing momentum, 2015 saw the biosimilar genie fully emerge from the bottle

- PMLiVE

The tribe has spoken

Who gets to decide which profit margin is acceptable?

- PMLiVE

Size matters?

Pfizer’s $160bn deal to acquire Allergan will challenge the new company to show that big is better

- PMLiVE

Brand teams: They’re not what you think they are

Head of Commercial Matt Bolton of Blue Latitude Health breaks down what we mean when we talk about eliminating the last silos in pharma marketing.

Blue Latitude Health

Blue Latitude Health to sponsor and co-present in the Innovation Track at ProcureCon Healthcare 2016

Blue Latitude Health’s Managing Director, Martin Brass, and Johnson & Johnson’s Director, David McKimm, to co-present on the topic “Optimising Your Marketing Spend in New Ways to Create Value for...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links